XBIOTECH INC. Prepaid Expense and Other Assets, Current
XBIOTECH INC. (XBIT) had Prepaid Expense and Other Assets, Current of $1.34 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Notes
us-gaap:PrepaidExpenseAndOtherAssetsCurrent · last filed 2026-08-13
- 2026-06-30: Prepaid Expense and Other Assets, Current $1.34M.
- 2026-03-31: Prepaid Expense and Other Assets, Current $1.29M.
- 2025-12-31: Prepaid Expense and Other Assets, Current $1.04M.
- 2025-09-30: Prepaid Expense and Other Assets, Current $1.06M.
| Period end | Prepaid Expense and Other Assets, Current |
|---|---|
| 2026-06-30 | $1.34M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $1.29M 10-Q · filed 2026-05-14 |
| 2025-12-31 | $1.04M 10-Q · filed 2026-08-13 |
| 2025-09-30 | $1.06M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.31M 10-Q · filed 2025-08-13 |
| 2025-03-31 | $1.15M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.03M 10-K · filed 2026-03-13 |
| 2024-09-30 | $1.04M 10-Q · filed 2024-11-13 |
| 2024-06-30 | $1.12M 10-Q · filed 2024-08-12 |
| 2024-03-31 | $1.07M 10-Q · filed 2024-05-10 |
| 2023-12-31 | $760.00K 10-K · filed 2025-03-18 |
| 2023-09-30 | $879.00K 10-Q · filed 2023-11-09 |
| 2023-06-30 | $947.00K 10-Q · filed 2023-08-11 |
| 2023-03-31 | $703.00K 10-Q · filed 2023-05-10 |
| 2022-12-31 | $601.00K 10-K · filed 2024-03-15 |
| 2022-09-30 | $621.00K 10-Q · filed 2022-11-09 |
| 2022-06-30 | $545.00K 10-Q · filed 2022-08-10 |
| 2022-03-31 | $632.00K 10-Q · filed 2022-05-10 |
| 2021-12-31 | $934.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $375.00K 10-Q · filed 2021-11-09 |
| 2021-06-30 | $382.00K 10-Q · filed 2021-08-09 |
| 2021-03-31 | $6.29M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $582.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $439.00K 10-Q · filed 2020-11-09 |
| 2020-06-30 | $802.00K 10-Q · filed 2020-08-10 |
| 2020-03-31 | $1.18M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.67M 10-K · filed 2021-03-16 |
| 2019-09-30 | $573.00K 10-Q · filed 2019-11-12 |
| 2019-06-30 | $678.00K 10-Q · filed 2019-08-09 |
| 2019-03-31 | $963.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $1.19M 10-K · filed 2020-03-16 |
| 2018-09-30 | $457.00K 10-Q · filed 2018-10-31 |
| 2018-06-30 | $917.00K 10-Q · filed 2018-08-09 |
| 2018-03-31 | $1.33M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.56M 10-K/A · filed 2019-03-15 |
| 2017-09-30 | $1.31M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.35M 10-Q · filed 2017-08-08 |
| 2017-03-31 | $2.45M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $2.61M 10-K · filed 2018-03-16 |
| 2016-09-30 | $2.05M 10-Q · filed 2016-11-14 |
| 2016-06-30 | $1.53M 10-Q · filed 2016-08-12 |
| 2016-03-31 | $1.61M 10-Q · filed 2016-05-13 |
| 2015-12-31 | $1.99M 10-K · filed 2017-03-16 |
| 2015-09-30 | $1.91M 10-Q · filed 2015-11-13 |
| 2015-06-30 | $2.97M 10-Q · filed 2015-08-14 |
| 2015-03-31 | $493.00K 10-Q · filed 2015-06-18 |
| 2014-12-31 | $411.00K 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |